Alan E. Smith, Senior Vice President at GENZYME CORP (GENZ), sold 18,455 shares at $79.70 ($1.5M) on 2008-07-15, disclosed to the SEC on 2008-08-04.
Scheduled sale ($1.5M) by Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| GHM | BUY | 2020-03-06 | $13K | — | Filing → |
| GHM | SELL | 2018-06-05 | $347K | — | Filing → |
| GHM | SELL | 2017-03-07 | $12K | — | Filing → |